Currently, there are 1.11B common shares owned by the public and among those 1.10B shares have been available to trade.
The company’s stock has a 5-day price change of -0.35% and -34.86% over the past three months. MU shares are trading 6.52% year to date (YTD), with the 12-month market performance up to 30.45% higher. It has a 12-month low price of $63.83 and touched a high of $157.54 over the same period. MU has an average intraday trading volume of 25.25 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.14%, -10.30%, and -13.37% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Micron Technology Inc. (NASDAQ: MU) shares accounts for 80.16% of the company’s 1.11B shares outstanding.
It has a market capitalization of $100.79B and a beta (3y monthly) value of 1.18. The earnings-per-share (ttm) stands at -$1.42. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.82% over the week and 3.92% over the month.
Earnings per share for the fiscal year are expected to increase by 127.14%, and 653.27% over the next financial year.
Looking at the support for the MU, a number of firms have released research notes about the stock. TD Cowen stated their Buy rating for the stock in a research note on September 19, 2024, with the firm’s price target at $160-$115. Wells Fargo coverage for the Micron Technology Inc. (MU) stock in a research note released on September 18, 2024 offered a Overweight rating with a price target of $175. Morgan Stanley was of a view on September 16, 2024 that the stock is Equal-Weight, while Exane BNP Paribas gave the stock Underperform rating on September 12, 2024, issuing a price target of $140- $67. Needham on their part issued Buy rating on August 26, 2024.
